BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acevedo OA, Díaz FE, Beals TE, Benavente FM, Soto JA, Escobar-Vera J, González PA, Kalergis AM. Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus. Front Cell Infect Microbiol 2019;9:75. [PMID: 30984626 DOI: 10.3389/fcimb.2019.00075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tang A, Chen Z, Cox KS, Su HP, Callahan C, Fridman A, Zhang L, Patel SB, Cejas PJ, Swoyer R, Touch S, Citron MP, Govindarajan D, Luo B, Eddins M, Reid JC, Soisson SM, Galli J, Wang D, Wen Z, Heidecker GJ, Casimiro DR, DiStefano DJ, Vora KA. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nat Commun 2019;10:4153. [PMID: 31515478 DOI: 10.1038/s41467-019-12137-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
2 Wang Z, Geng PL. CD32a polymorphism rs1801274 affects the risk of Kawasaki disease. Artif Cells Nanomed Biotechnol 2020;48:620-6. [PMID: 32072832 DOI: 10.1080/21691401.2019.1645156] [Reference Citation Analysis]
3 Yu X, Lakerveld AJ, Imholz S, Hendriks M, Ten Brink SCA, Mulder HL, de Haan K, Schepp RM, Luytjes W, de Jong MD, van Beek J, van Kasteren PB. Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults. mSphere 2020;5:e00577-20. [PMID: 32878928 DOI: 10.1128/mSphere.00577-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Holgado MP, Raiden S, Sananez I, Seery V, De Lillo L, Maldonado LL, Kamenetzky L, Geffner J, Arruvito L. Fcγ Receptor IIa (FCGR2A) Polymorphism Is Associated With Severe Respiratory Syncytial Virus Disease in Argentinian Infants. Front Cell Infect Microbiol 2020;10:607348. [PMID: 33392111 DOI: 10.3389/fcimb.2020.607348] [Reference Citation Analysis]
5 van Erp EA, Lakerveld AJ, de Graaf E, Larsen MD, Schepp RM, Hipgrave Ederveen AL, Ahout IM, de Haan CA, Wuhrer M, Luytjes W, Ferwerda G, Vidarsson G, van Kasteren PB. Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation. Clin Transl Immunology 2020;9:e1112. [PMID: 32099650 DOI: 10.1002/cti2.1112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hwang HS, Lee YT, Kim KH, Seo HS, Yang KS, Cho H, Kang SM. Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection. Vaccines (Basel) 2021;9:232. [PMID: 33800349 DOI: 10.3390/vaccines9030232] [Reference Citation Analysis]
7 Gaur P, Zaffran I, George T, Alekberli FR, Ben-Zimra M, Levi-Schaffer F. The regulatory role of eosinophils in viral, bacterial, and fungal infections. Clin Exp Immunol 2022:uxac038. [PMID: 35467728 DOI: 10.1093/cei/uxac038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]